<sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of Amino Acid Conjugates of Terpenoids
Version 3 2023-04-04, 01:18
Version 2 2023-03-31, 08:15
Version 1 2023-03-29, 08:13
figure
posted on 2023-04-04, 01:18 authored by Motohiko Ukiya, Tomoyuki Sekine, Naoto Shimizu, Hiroyuki Akazawa, Minoru Tanigawa, Yusuke Suzuki, Atsuyoshi Nishina<p> </p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of <em>ent</em>-16β,19-dihydroxybeyerane di-<em>O</em>-glycine conjugate (compound 5)…p.1–2</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of <em>ent</em>-16β,19-dihydroxybeyerane di-<em>O</em>-l-alanine conjugate (compound 6)…p.3–4</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of <em>ent</em>-16β,19-dihydroxybeyerane di-<em>O</em>-alanine conjugate (compound 7)…p.5–6</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of <em>ent</em>-16β,19-dihydroxybeyerane di-<em>O</em>-L-isoleucine conjugate (compound 8)…p.7–8</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of <em>ent</em>-16β,19-dihydroxybeyerane di-<em>O</em>-D-isoleucine conjugate (compound 9)…p.9–10</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of <em>ent</em>-16β,19-dihydroxybeyerane di-<em>O</em>-L-valine conjugate (compound 10)…p.11–12</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of <em>ent</em>-16β,19-dihydroxybeyerane di-<em>O</em>-D-valine conjugate (compound 11)…p.13–14</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of <em>ent</em>-16β,19-dihydroxybeyerane di-<em>O</em>-L-phenylalanine conjugate (compound12)…p.15–16</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of <em>ent</em>-16β,19-dihydroxybeyerane di-<em>O</em>-D-phenylalanine conjugate (compound 13)…p.17–18</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of <em>ent</em>-16β,19-Dihydroxybeyerane di-<em>O</em>-succinate (compound 14)…p.19–20</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of <em>ent</em>-16β,19-Dihydroxybeyerane <em>N</em>,<em>N</em>-dimethylglycine conjugate (compound 15)…p.21–22</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of erythrodiol di-<em>O</em>-glycine conjugate (compound 19)…p.23–24</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of erythrodiol di-<em>O</em>-L-alanine conjugate (compound 20)…p.25–26</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of erythrodiol di-<em>O</em>-D-alanine conjugate (compound 21)…p.27–28</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of erythrodiol di-<em>O</em>-L-leucine conjugate (compound 22)…p.29–30</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of erythrodiol di-<em>O</em>-D-leucine conjugate (compound 23)…p.31–32</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of erythrodiol di-<em>O</em>-L-valine conjugate (compound 24)…p.33–34</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of erythrodiol di-<em>O</em>-D-valine conjugate (compound 25)…p.35–36</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of erythrodiol di-<em>O</em>-L-phenylalanine conjugate (compound 26)…p.37–38</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of erythrodiol di-<em>O</em>-D-phenylalanine conjugate (compound 27)…p.39–40</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of Erythrodiol di-<em>O</em>-succinate (compound 28)…p.41–42</p>
<p><sup>1</sup>H-NMR, <sup>13</sup>C-NMR, and HRMS of Erythrodiol <em>N</em>,<em>N</em>-dimethylglycine conjugate (compound 29)…p.43–44</p>
<p>Apoptosis inducing effect by <em>ent</em>-16β,19-dihydroxybeyerane di-<em>O</em>-L-isoleucine conjugate (compound 8)…p.45–46</p>
